Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 juil. 2005 16h16 HE | Source: Discovery Laboratories, Inc.

Discovery Labs Submits Response to FDA Approvable Letter for Surfaxin for RDS in Premature Infants

WARRINGTON, Pa., July 29, 2005 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), today announced that it has submitted its response to the Approvable Letter received from the U.S. Food and...
19 mai 2005 09h49 HE | Source: Advanced Plant Pharmaceuticals, Inc.

Advanced Plant Pharmaceuticals, Inc.'s Majority Owned Subsidiary, Mazal Plant Pharmaceuticals Inc., Receives Investigational New Drug Application Approval from the FDA for HDL/Cholesterol Improvement Drug

NEW YORK, May 19, 2005 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and its majority owned subsidiary, Mazal Plant Pharmaceuticals Inc., announced today that Mazal received...
17 avr. 2005 15h00 HE | Source: Integra LifeSciences Holdings Corporation

Integra NeuroSciences Launches Suturable DuraGen Dural Regeneration Matrix

PLAINSBORO, N.J., April 17, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced it has received 510(k) clearance from the United States Food and Drug...
11 nov. 2004 07h01 HE | Source: Encysive Pharmaceuticals Inc.

FDA Grants Encysive Orphan Drug Designation For Thelin

HOUSTON, Nov. 11, 2004 (PRIMEZONE) -- Encysive Pharmaceuticals (NASDAQ:ENCY) announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Thelin(tm)...
23 avr. 2002 16h31 HE | Source: Integra LifeSciences Holdings Corporation

Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures

PLAINSBORO, N.J., April 23, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the U.S. Food and Drug Administration (FDA) has approved its pre-market...